Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

尼菲迪平的GITS是什么?

D D Breimer, J Urquhart

    Lancet (London, England)
    |January 30, 1993
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Surgical practice variation and outcomes regarding single-level posterior approach for degenerative lumbar spondylolisthesis: a Canadian Spine Outcomes Research Network (CSORN) study.

    The spine journal : official journal of the North American Spine Society·2025
    Same author

    Impact of Covid-19 on farming systems in Europe through the lens of resilience thinking.

    Agricultural systems·2022
    Same author

    Commentary on "A Framework for Quantifying the Influence of Adherence and Dose Individualization".

    Clinical pharmacology and therapeutics·2015
    Same author

    Methods for measuring, enhancing, and accounting for medication adherence in clinical trials.

    Clinical pharmacology and therapeutics·2014
    Same author

    Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

    Pharmaceutical research·2013
    Same author

    Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

    Pharmaceutical research·2013
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章